Bathmapriya Balakrishnan

Bathmapriya Balakrishnan

Auto-generated profile, based on publicly available information

Bathmapriya Balakrishnan

Division of Pulmonary Medicine, Integrated Hospital Institute, Cleveland Clinic, Cleveland, OH, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Closed access
RSRichard Shellenberger
Richard Shellenberger
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
SASindhu Avula
Sindhu Avula
AEAriadne Ebel
Ariadne Ebel
SSSufiya Shaik
Sufiya Shaik
Release date: December 1, 2017Expiration date: November 30, 2018Estimated time of completion: 1 hourClick here to start this CME activity.Click here to complete post-test and CME certificate.ABSTRACTWe reviewed the evidence for the diagnostic accuracy of the physical examination in diagnosing pneumonia, pleural effusion, chronic obstructive pulmonary disease, and congestive heart failure in patients with dyspnea and found that the physical examination has reliable diagnostic accuracy for these common conditions.

11 April 2023 in Chest
Verified
Journal Article
Open access
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
SCSean J. Callahan
Sean J. Callahan
SCSujith V. Cherian
Sujith V. Cherian
ASAbirami Subramanian
Abirami Subramanian
SSSauradeep Sarkar
Sauradeep Sarkar
MSMary-Beth Scholand
Mary-Beth Scholand
Climate change adversely impacts global health. Increasingly, the temperature variability, inclement weather, declining air quality, and growing food and clean water supply insecurities threaten human health. Earth's temperature is projected to increase up to 6.4°C by the end of the 21st century, exacerbating the threat. The public and healthcare professionals, including pulmonologists, perceive the detrimental effects of climate change and air pollution; they support efforts to mitigate its effects. In fact, there is strong evidence of premature cardiopulmonary deaths associated with air pollution exposure via inhalation through the respiratory system, which functions as a portal of entry. However, little guidance is available for pulmonologists in recognizing the effects of climate change and air pollution on the diverse range of pulmonary disorders. To competently educate and mitigate risk for patients, pulmonologists must be armed with evidence-based findings of the impact of climate change and air pollution on specific pulmonary diseases. Our goal is to provide pulmonologists with the background and tools to improve patients' health and prevent adverse outcomes despite climate change-imposed threats. In this review, we detail current evidence of climate change and air pollution impact on a diverse range of pulmonary disorders. Knowledge enables a proactive and individualized approach towards prevention strategies for patients rather than merely treating ailments reactively.

8 September 2022 in Current Pulmonology Reports
Verified
Journal Article
Open access
PDF file
JAJaveria Anwar
Javeria Anwar
WKWing Tai Kong
Wing Tai Kong
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
Purpose of Review: Hypersensitivity pneumonitis (HP) is an immune-mediated disease triggered by a known or unknown antigen. While reversible in the early stages of disease, progression toward irreversible pulmonary fibrosis may occur. This narrative review summarizes recent publications highlighting a methodical approach toward the diagnosis, classification, and management of fibrotic and nonfibrotic HP. Recent Findings: Establishing the diagnosis of HP is often challenging given its variable clinical course, extensive inciting agents, and overlapping features with other interstitial lung diseases. Recently, HP has been re-classified into nonfibrotic and fibrotic subtypes based on radiographic and histopathological features. Chronic fibrotic HP is associated with significant functional impairment and increased mortality. In addition to antigen avoidance, immunosuppression is the cornerstone of management in nonfibrotic HP. Antifibrotic agents have emerged as a therapeutic option in halting the progression of chronic fibrotic HP. Summary: The combination of clinical, radiographical, and histopathological data will assist in increasing the diagnostic certainty of HP. The new dichotomization of HP is thought to provide better prognostication for patients. This review provides clinicians with a current and evidence-based approach toward the management of patients with HP.

22 March 2023 in JMIR Formative Research
Verified
Journal Article
Open access
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
LHLucas Hamrick
Lucas Hamrick
AAAriful Alam
Ariful Alam
JTJesse Thompson
Jesse Thompson
Background: Post-intensive care syndrome (PICS) affects up to 50% of intensive care unit (ICU) survivors, leading to long-term neurocognitive, psychosocial, and physical impairments. Approximately 80% of COVID-19 pneumonia ICU patients are at elevated risk for developing acute respiratory distress syndrome (ARDS). Survivors of COVID-19 ARDS are at high risk of unanticipated health care utilization postdischarge. This patient group commonly has increased readmission rates, long-term decreased mobility, and poorer outcomes. Most multidisciplinary post-ICU clinics for ICU survivors are in large urban academic medical centers providing in-person consultation. Data are lacking on the feasibility of providing telemedicine post-ICU care for COVID-19 ARDS survivors. Objective: We explored the feasibility of instituting a COVID-19 ARDS ICU survivor telemedicine clinic and examined its effect on health care utilization post-hospital discharge. Methods: This randomized, unblinded, single-center, parallel-group, exploratory study was conducted at a rural, academic medical center. Study group (SG) participants underwent a telemedicine visit within 14 days of discharge, during which a 6-minute walk test (6MWT), EuroQoL 5-Dimension (EQ-5D) questionnaire, and vital signs logs were reviewed by an intensivist. Additional appointments were arranged as needed based on the outcome of this review and tests. The control group (CG) underwent a telemedicine visit within 6 weeks of discharge and completed the EQ-5D questionnaire; additional care was provided as needed based on findings in this telemedicine visit. Results: Both SG (n=20) and CG (n=20) participants had similar baseline characteristics and dropout rate (10%). Among SG participants, 72% (13/18) agreed to pulmonary clinic follow-up, compared with 50% (9/18) of CG participants (P=.31). Unanticipated visits to the emergency department occurred for 11% (2/18) of the SG compared with 6% (1/18) of the CG (>.99). The rate of pain or discomfort was 67% (12/18) in the SG compared with 61% (11/18) in the CG (P=.72). The anxiety or depression rate was 72% (13/18) in the SG versus 61% (11/18; P=.59) in the CG. Participants’ mean self-assessed health rating scores were 73.9 (SD 16.1) in the SG compared with 70.6 (SD 20.9) in the CG (P=.59). Both primary care physicians (PCPs) and participants in the SG perceived the telemedicine clinic as a favorable model for postdischarge critical illness follow-up in an open-ended questionnaire regarding care. Conclusions: This exploratory study found no statistically significant results in reducing health care utilization postdischarge and health-related quality of life. However, PCPs and patients perceived telemedicine as a feasible and favorable model for postdischarge care among COVID-19 ICU survivors to facilitate expedited subspecialty assessment, decrease unanticipated postdischarge health care utilization, and reduce PICS. Further investigation is warranted to determine the feasibility of incorporating telemedicine-based post-hospitalization follow-up for all medical ICU survivors that may show improvement in health care utilization in a larger population.

31 March 2016 in Journal of Investigative Medicine High Impact Case Reports
Verified
Journal Article
Open access
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
SSSufiya Shaik
Sufiya Shaik
IBIrina Burman-Solovyeva
Irina Burman-Solovyeva
Introduction. We present an unusual case of metastatic lobular breast carcinoma. Typical areas of metastasis include bone, gynecological organs, peritoneum, retroperitoneum, and gastrointestinal (GI) tract, in order of frequency. With regard to GI metastasis, extrahepatic represents a rare site. Case. Two years after being diagnosed with invasive lobular breast carcinoma, a 61-year-old female complained of 3 months of nonspecific abdominal pain and diarrhea. A colonoscopy revealed 5 tubular adenomatous polyps in the ascending and transverse colon. Contrast computed tomography (CT) of the abdomen and pelvis was done 7 months after the colonoscopy to further evaluate persistent diarrhea. The CT results were consistent with infectious or inflammatory enterocolitis. Despite conservative management, symptoms failed to improve and a repeat diagnostic colonoscopy was obtained. Random colonic biopsies revealed metastatic high-grade adenocarcinoma of the colon. Discussion. Metastatic lobular breast carcinoma to the GI tract can distort initial interpretation of endoscopic evaluation with lesions mimicking inflammation. The interval between discovery of GI metastasis and diagnosis of lobular breast cancer can vary widely from synchronous to 30 years; however, progression is most often much sooner. Nonspecific symptoms and subtle appearance of metastatic lesions may confound the diagnosis. A high index of suspicion is needed for possible metastatic spread to the GI tract in patients with a history of invasive lobular breast carcinoma. Perhaps, patients with nonspecific GI symptoms should have an endoscopic examination with multiple random biopsies as invasive lobular carcinoma typically mimics macroscopic changes consistent with colitis.

7 September 2022 in Current Pulmonology Reports
Verified
Journal Article
Open access
PDF file
LSLauren Stawovy
Lauren Stawovy
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
Purpose of Review: The increase in wildfire prevalence and severity has generated alarm as wildfire air pollution is associated with significant respiratory morbidity. We aim to summarize the pathophysiology of wildfire air pollution causing lung disease, current knowledge of pulmonary health effects, and precautionary guidance to the public. We also propose specific guidance for high-risk patients during wildfires. Recent Findings: Health effects of wildfire air pollution have been difficult to evaluate; however, respiratory morbidity has been firmly established including exacerbation of known pulmonary disease and increased hospitalizations, emergency department visits, and dispensation of reliever medications. Public health agencies and officials provide wildfire preparation recommendations and active updates to the public during a wildfire event but fail to address specific needs of chronic lung disease patients considered high-risk for pulmonary complications. To fill this void, it is increasingly important for pulmonary physicians to understand wildfire-related pulmonary morbidity and provide specific guidance to their patients. Summary: This review summarizes the health effects of wildfire air pollution and provides guidance for the management of high-risk patients during wildfires.